LOSARTAN NORMALIZES THE PLASMA LEVELS OF TGF-β1 IN A RANDOM, CROSSOVER STUDY (LOSARTAN VS. AMLODIPINE) IN RENAL TRANSPLANT PATIENTS TREATED WITH CsA. | Publicación